Who is sponsoring NCT03389074?

NCT03389074 is sponsored by Seoul National University Hospital.

What condition does NCT03389074 study?

NCT03389074 studies Atrial Fibrillation.

What drugs are being tested in NCT03389074?

Interventions: Radiofrequency catheter ablation.

What is the status of NCT03389074?

NCT03389074 is currently UNKNOWN.

Last reviewed 2020-03-18 · How we verify

Evaluation of Optimal Ablation Index for Pulmonary Vein Isolation in Patients With AF Prospective Registry

NCT03389074 UNKNOWN

In this study, the investigators identify the optimal AI value for achieving good acute outcomes in PVI. Through the Phase 1 study, the investigators will prospectively analyze data including ablation parameters, AI and acute outcomes of 20 patients performed PVI with conventional ablation strategy (AI-blinded). After Phase 1 study results, optimal target AI value for each predefined PV segment will be determined. Then, by applying optimal AI values derived from the Phase 1 study, the investigators will evaluate the feasibility of the AI-guided procedure and verify the optimal AI value for acute PVI outcomes in the prospectively enrolled patients (n = 30) in the Phase 2 study.

Details

Lead sponsor	Seoul National University Hospital
Status	UNKNOWN
Enrolment	70
Start date	Mon Jan 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu Dec 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Atrial Fibrillation

Interventions

Radiofrequency catheter ablation

Countries

South Korea